bioAffinity Technologies Inc

BIAF | Healthcare | NASDAQ
$4.08
-0.11 (-2.51%)

Key Metrics

Market Cap
$18.33M
P/E Ratio
-0.47
EPS
$-8.66
Beta
N/A
Dividend Yield
N/A
ROE
-385.19%
Current Ratio
2.60

Company Information

Industry
Medical Diagnostics Research

About bioAffinity Technologies Inc

bioAffinity Technologies Inc a biotechnology company engages in developing noninvasive diagnostic tests and targeted cancer therapeutics The company offers CyPath lung a diagnostic test for early detection of lung cancer It also researches targeted therapies to treat cancer at the cellular level The company was founded in 2014 and is based in San Antonio Texas

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2026-03-13 $-1.11 $-2.70 +-58.9%
2025-11-14 $-2.70 $-2.70 +0.0%
2025-08-14 $-3.90 $-2.70 44.4%
2025-05-15 $-0.16 $-0.16 +0.0%

Financial Ratios (TTM)

Gross Margin
23.21%
Operating Margin
-171.58%
Net Margin
-241.97%
ROA
-136.03%
Price to Book
0.99
Price to Sales
3.05